References
- Avilés A., García E. L., Guzmán R., et al. Estudio comparative) de dosis altas de arabinosido de citosina en combination con cisplatino y dexametasonaen pacientes con linfoma refractario. Rev. Invest. Clin. 1991; 43: 146–50
- Bosly A., Coiffier B., Gisselbrecht C., et al. Bone marrow transplantation prolongs survival after relapse in aggressive lymphoma treated with the LNH-84 regimen. J. Clin. Oncol. 1991; 10: 1615–23
- Lazarus H. M., Crilley P., Ciobanu N., et al. High dose carmustine, etoposide and cisplatinum and autologous bone marrow transplantation for relapsed and refractory lymphoma. J. Clin. Oncol. 1991; 10: 1083–89
- Dreyfus C., Leblond V., Belanguer C., et al. Peripheral blood stem cells collection and autografting in high risk lymphomas. Bone Marrow Transplant. 1991; 10: 409–13
- Ho A. D., Del Valle F., Engerhard M., et al. Mitoxantrone/high dose Ara C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. Cancer 1990; 66: 423–30
- Gianni A. M., Bregni M., Sienna S., et al. Recombinant human granulocyte-macrophage colony-stimulating factor reduce hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J. Clin. Oncol. 1990; 8: 768–78
- Yoshida T., Nakamura S., Ohtake S., et al. Effects of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma. Cancer 1990; 66: 1904–09
- Biesma B., Vellenga E., Willemze P. H. B., de Vries E. G. E. Effects of hematopoietic growth factors on chemotherapy induced myelosuppression. Crit. Rev. Oncol. Hematol. 1992; 13: 107–34
- Avilés A., Díaz-Maqueo J. C., Torras V. Tratamiento de linfomas malignos refractarios con cisplatino, vinblastina y bleomicina. Rev. Invest. Clin. 1990; 42: 99–105
- Avilés A., Díaz-Maqueo J. C., Talavera A., Nambo M. J., Garcia E. L. Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy. Leukemia and Lymphoma 1994, (in press)
- Avilés A., Delgado S., Nambo M. J., Alatriste S., Díaz-Maqueo J. C. Adjuvant radiotherapy to sites of previous bulky disease in patients with stage IV diffuse large cell lymphoma. Intern. J. Radiat. Oncol. Biol. Phys. 1994, (in press)
- Wilson W. H., Bryant G., Bates S., et al. EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J. Clin. Oncol. 1993; 11: 1573–82
- Klump T. R., Mangan L., Glenn D. R., et al. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral stem cell transplantation in patients with poor prognosis Hodgkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplant. 1993; 12: 337–45
- Vose J. M., Anderson J. R., Kessinger A., et al. High dose chemotherapy and autologous hematopoietic stem cell transplantation for aggressive non-Hodgkin's lymphoma. J. Clin. Oncol. 1993; 11: 1846–55
- Laporte J. P., Fouillard L., Dovay L., et al. GM-CSF instead of autologous bone marrow transplantation after BEAM regimen. Lancet 1991; 338: 601–02